Re: 'Real world clinical outcome of cefiderocol for treatment of multidrug-resistant nonfermenting gram-negative bacilli infections' by Hoellinger et al
- PMID: 36739087
- DOI: 10.1016/j.cmi.2023.01.022
Re: 'Real world clinical outcome of cefiderocol for treatment of multidrug-resistant nonfermenting gram-negative bacilli infections' by Hoellinger et al
Keywords: Antimicrobial susceptibility testing; Bloodstream infection; Cefiderocol; Combination therapy; Heteroresistance; Immunocompromised patient; Nonfermenters. outcomes.
Comment in
-
Re: real world clinical outcome of cefiderocol for treatment of multidrug-resistant non-fermenting gram-negative bacilli infections: author's response.Clin Microbiol Infect. 2023 Jun;29(6):812-813. doi: 10.1016/j.cmi.2023.02.019. Epub 2023 Mar 5. Clin Microbiol Infect. 2023. PMID: 36871827 No abstract available.
Comment on
-
Real-world clinical outcome of cefiderocol for treatment of multidrug-resistant non-fermenting, gram negative bacilli infections: a case series.Clin Microbiol Infect. 2023 Mar;29(3):393-395. doi: 10.1016/j.cmi.2022.11.005. Epub 2022 Nov 18. Clin Microbiol Infect. 2023. PMID: 36410645 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources